Literature DB >> 21839744

Structural characterization and membrane localization of ExsB from the type III secretion system (T3SS) of Pseudomonas aeruginosa.

Thierry Izoré1, Caroline Perdu, Viviana Job, Ina Attree, Eric Faudry, Andréa Dessen.   

Abstract

Pseudomonas aeruginosa is an opportunistic human pathogen that employs a finely tuned type III secretion system (T3SS) to inject toxins directly into the cytoplasm of target cells. ExsB is a 15.6-kDa protein encoded in a T3SS transcription regulation operon that displays high sequence similarity to YscW, a lipoprotein from Yersinia spp. whose genetic neighborhood also involves a transcriptional regulator, and has been shown to play a role in the stabilization of the outer membrane ring of the T3SS. Here, we show that ExsB is expressed in P. aeruginosa upon induction of the T3SS, and subcellular fractionation studies reveal that it is associated with the outer membrane. The high-resolution crystal structure of ExsB shows that it displays a compact β-sandwich fold with interdependent β-sheets. ExsB possesses a large patch of basic residues that could play a role in membrane recognition, and its structure is distinct from that of MxiM, a lipoprotein involved in secretin stabilization in Shigella, as well as from those of Pil lipoproteins involved in pilus biogenesis. These results reveal that small lipoproteins involved in formation of the outer membrane secretin ring display clear structural differences that may be related to the different functions they play in these systems.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21839744     DOI: 10.1016/j.jmb.2011.07.043

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  15 in total

Review 1.  Shigella: a model of virulence regulation in vivo.

Authors:  Benoit Marteyn; Anastasia Gazi; Philippe Sansonetti
Journal:  Gut Microbes       Date:  2012-03-01

Review 2.  Structural biology of type VI secretion systems.

Authors:  Eric Cascales; Christian Cambillau
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-04-19       Impact factor: 6.237

3.  Identification of YsaP, the Pilotin of the Yersinia enterocolitica Ysa Type III Secretion System.

Authors:  Reina Rau; Andrew J Darwin
Journal:  J Bacteriol       Date:  2015-06-15       Impact factor: 3.490

Review 4.  Bacterial secretins: Mechanisms of assembly and membrane targeting.

Authors:  Yuri Rafael de Oliveira Silva; Carlos Contreras-Martel; Pauline Macheboeuf; Andréa Dessen
Journal:  Protein Sci       Date:  2020-02-19       Impact factor: 6.725

Review 5.  On the road to structure-based development of anti-virulence therapeutics targeting the type III secretion system injectisome.

Authors:  Bronwyn J E Lyons; Natalie C J Strynadka
Journal:  Medchemcomm       Date:  2019-06-20       Impact factor: 3.597

Review 6.  The type II secretion system: biogenesis, molecular architecture and mechanism.

Authors:  Konstantin V Korotkov; Maria Sandkvist; Wim G J Hol
Journal:  Nat Rev Microbiol       Date:  2012-04-02       Impact factor: 60.633

7.  Pharmacological activation of Rap1 antagonizes the endothelial barrier disruption induced by exotoxins ExoS and ExoT of Pseudomonas aeruginosa.

Authors:  Stéphanie Bouillot; Ina Attrée; Philippe Huber
Journal:  Infect Immun       Date:  2015-02-17       Impact factor: 3.441

8.  Crystal structure of the pilotin from the enterohemorrhagic Escherichia coli type II secretion system.

Authors:  Konstantin V Korotkov; Wim G J Hol
Journal:  J Struct Biol       Date:  2013-02-28       Impact factor: 2.867

9.  Genomic Features of Environmental and Clinical Vibrio parahaemolyticus Isolates Lacking Recognized Virulence Factors Are Dissimilar.

Authors:  J Ronholm; N Petronella; C Chew Leung; A W Pightling; S K Banerjee
Journal:  Appl Environ Microbiol       Date:  2015-12-04       Impact factor: 4.792

10.  ExsB is required for correct assembly of the Pseudomonas aeruginosa type III secretion apparatus in the bacterial membrane and full virulence in vivo.

Authors:  Caroline Perdu; Philippe Huber; Stéphanie Bouillot; Ariel Blocker; Sylvie Elsen; Ina Attrée; Eric Faudry
Journal:  Infect Immun       Date:  2015-02-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.